- Home
- NGD vs MLTX Comparison
NGD vs MLTX Comparison
Compare NGD & MLTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NGD
- MLTX
- Stock Information
- Founded
- NGD N/A
- MLTX 2021
- Country
- NGD Canada
- MLTX Switzerland
- Employees
- NGD N/A
- MLTX N/A
- Industry
- NGD
- MLTX Biotechnology: Pharmaceutical Preparations
- Sector
- NGD
- MLTX Health Care
- Exchange
- NGD Nasdaq
- MLTX Nasdaq
- Market Cap
- NGD 2.5B
- MLTX 2.8B
- IPO Year
- NGD 2004
- MLTX N/A
- Fundamental
- Price
- NGD $3.61
- MLTX $39.86
- Analyst Decision
- NGD Buy
- MLTX Strong Buy
- Analyst Count
- NGD 4
- MLTX 8
- Target Price
- NGD $3.23
- MLTX $80.50
- AVG Volume (30 Days)
- NGD 20.4M
- MLTX 423.8K
- Earning Date
- NGD 04-29-2025
- MLTX 05-06-2025
- Dividend Yield
- NGD N/A
- MLTX N/A
- EPS Growth
- NGD N/A
- MLTX N/A
- EPS
- NGD 0.14
- MLTX N/A
- Revenue
- NGD $924,500,000.00
- MLTX N/A
- Revenue This Year
- NGD $25.37
- MLTX $103.95
- Revenue Next Year
- NGD $42.62
- MLTX N/A
- P/E Ratio
- NGD $26.47
- MLTX N/A
- Revenue Growth
- NGD 17.55
- MLTX N/A
- 52 Week Low
- NGD $1.66
- MLTX $36.52
- 52 Week High
- NGD $3.78
- MLTX $58.26
- Technical
- Relative Strength Index (RSI)
- NGD 70.14
- MLTX 47.41
- Support Level
- NGD $2.73
- MLTX $38.28
- Resistance Level
- NGD $3.48
- MLTX $42.27
- Average True Range (ATR)
- NGD 0.14
- MLTX 1.91
- MACD
- NGD 0.04
- MLTX 0.31
- Stochastic Oscillator
- NGD 81.91
- MLTX 58.14
About NGD New Gold Inc.
New Gold Inc participates in the development and operation of intermediate mining properties. The company has a portfolio of two primary assets which are also its operating segments: the Rainy River Mine and the New Afton Mine in Canada. The company also owns the Cerro San Pedro Mine in Mexico. The company derives revenue from the sale of gold, copper, and silver.
About MLTX MoonLake Immunotherapeutics
MoonLake Immunotherapeutics is a clinical-stage biotechnology company engaged in leveraging Nanobody technology to develop next-level medicines for immunologic diseases, including inflammatory skin and joint diseases.